The Clorox Company (NYSE:CLX) Receives $156.75 Consensus PT from Analysts

Shares of The Clorox Company (NYSE:CLXGet Free Report) have earned an average rating of “Reduce” from the thirteen ratings firms that are covering the firm, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $155.08.

CLX has been the subject of several research reports. Barclays dropped their price target on shares of Clorox from $139.00 to $134.00 and set an “underweight” rating for the company in a research note on Friday. DA Davidson lowered their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Wells Fargo & Company reduced their price target on Clorox from $161.00 to $155.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 2nd. Citigroup lowered their price objective on Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a research report on Monday. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th.

Get Our Latest Analysis on CLX

Clorox Price Performance

CLX opened at $140.77 on Friday. The stock’s 50-day moving average price is $147.29 and its 200 day moving average price is $157.05. Clorox has a 12-month low of $127.60 and a 12-month high of $171.37. The firm has a market cap of $17.34 billion, a price-to-earnings ratio of 38.46, a PEG ratio of 2.62 and a beta of 0.61. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the firm earned $2.16 EPS. As a group, sell-side analysts expect that Clorox will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.47%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is 133.33%.

Institutional Investors Weigh In On Clorox

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Brooklyn Investment Group lifted its holdings in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Redwood Park Advisors LLC acquired a new position in Clorox during the fourth quarter worth approximately $26,000. Continuum Advisory LLC lifted its stake in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the last quarter. Millstone Evans Group LLC acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $31,000. Finally, Wood Tarver Financial Group LLC purchased a new position in shares of Clorox during the fourth quarter worth approximately $31,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Company Profile

(Get Free Report

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.